Human cytomegalovirus modulates monocyte-mediated innate immune responses during short-term experimental latency in vitro

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9391-9405

  Noriega, Vanessa M ^a   Haye, Kester K ^a   Kraus, Thomas A ^a   Kowalsky, Shanna R ^a   Ge, Yongchao ^a   Moran, Thomas M ^a   Tortorella, Domenico ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CHEMOATTRACTANT; EOTAXIN 2; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 4; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL FUNCTION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS INFECTION; EXPERIMENTAL INFECTION; GENE EXPRESSION; HOST RESISTANCE; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE EVASION; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; INNATE IMMUNITY; LATENT VIRUS INFECTION; LIPOGENESIS; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; VIRUS LATENCY; VIRUS REACTIVATION;

ANTIGENS, CD14; CELL LINE; CELL LINEAGE; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION; HUMANS; IMMUNITY, INNATE; INFLAMMATION; MACROPHAGES; MONOCYTES; MYELOID CELLS; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VIRUS LATENCY;

EID: 84904910914     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00934-14     Document Type: Article

References (70)

1. Sissons JG, Carmichael AJ, McKinney N, Sinclair JH, Wills MR. 2002. Human cytomegalovirus and immunopathology. Springer Semin. Immunopathol. 24:169-185. http://dx.doi.org/10.1007/s00281-002-0104-0.
2. Sissons JG, Carmichael AJ. 2002. Clinical aspects and management of cytomegalovirus infection. J. Infect. 44:78-83. http://dx.doi.org/10.1053/jinf.2001.0949.
3. Fisher RA. 2009. Cytomegalovirus infection and disease in the new era of immunosuppression following solid organ transplantation. Transpl Infect. Dis. 11:195-202. http://dx.doi.org/10.1111/j.1399-3062.2009.00372.x.
4. Razonable RR. 2005. Epidemiology of cytomegalovirus disease in solid organ and hematopoietic stem cell transplant recipients. Am. J. Health Syst. Pharm. 62:S7-S13.
5. Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87:1763-1779. http://dx.doi.org/10.1099/vir.0.81891-0.
6. Saffert RT, Penkert RR, Kalejta RF. 2010. Cellular and viral control over the initial events of human cytomegalovirus experimental latency in CD34+ cells. J. Virol. 84:5594-5604. http://dx.doi.org/10.1128/JVI.00348-10.
7. Reeves MB, Sinclair JH. 2010. Analysis of latent viral gene expression in natural and experimental latency models of human cytomegalovirus and its correlation with histone modifications at a latent promoter. J. Gen. Virol. 91:599-604. http://dx.doi.org/10.1099/vir.0.015602-0.
8. Mendelson M, Monard S, Sissons P, Sinclair J. 1996. Detection of endogenous human cytomegalovirus in CD34+ bone marrow progenitors. J. Gen. Virol. 77:3099-3102. http://dx.doi.org/10.1099/0022-1317-77-12-3099.
9. Taylor-Wiedeman J, Sissons JG, Borysiewicz LK, Sinclair JH. 1991. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J. Gen. Virol. 72:2059-2064. http://dx.doi.org/10.1099/0022-1317-72-9-2059.
10. Goodrum FD, Jordan CT, High K, Shenk T. 2002. Human cytomegalovirus gene expression during infection of primary hematopoietic progenitor cells: a model for latency. Proc. Natl. Acad. Sci. U. S. A. 99:16255-16260. http://dx.doi.org/10.1073/pnas.252630899.
11. Kondo K, Xu J, Mocarski ES. 1996. Human cytomegalovirus latent gene expression in granulocyte-macrophage progenitors in culture and in seropositive individuals. Proc. Natl. Acad. Sci. U. S. A. 93:11137-11142. http://dx.doi.org/10.1073/pnas.93.20.11137.
12. Hargett D, Shenk TE. 2010. Experimental human cytomegalovirus latency in CD14+ monocytes. Proc. Natl. Acad. Sci. U. S. A. 107:20039-20044. http://dx.doi.org/10.1073/pnas.1014509107.
13. Soderberg-Naucler C, Fish KN, Nelson JA. 1997. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91:119-126. http://dx.doi.org/10.1016/S0092-8674(01)80014-3.
14. Haye K, Burmakina S, Moran T, Garcia-Sastre A, Fernandez-Sesma A. 2009. The NS1 protein of a human influenza virus inhibits type I interferon production and the induction of antiviral responses in primary human dendritic and respiratory epithelial cells. J. Virol. 83:6849-6862. http://dx.doi.org/10.1128/JVI.02323-08.
15. Sinzger C, Schmidt K, Knapp J, Kahl M, Beck R, Waldman J, Hebart H, Einsele H, Jahn G. 1999. Modification of human cytomegalovirus tropism through propagation in vitro is associated with changes in the viral genome. J. Gen. Virol. 80:2867-2877.
16. Noriega VM, Hesse J, Gardner TJ, Besold K, Plachter B, Tortorella D. 2012. Human cytomegalovirus US3 modulates destruction of MHC class I molecules. Mol. Immunol. 51:245-253. http://dx.doi.org/10.1016/j.molimm.2012.03.024.
17. Bolstad BM, Irizarry RA, Astrand M, Speed TP. 2003. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19:185-193. http://dx.doi.org/10.1093/bioinformatics/19.2.185.
18. Du P, Kibbe WA, Lin SM. 2008. lumi: a pipeline for processing Illumina microarray. Bioinformatics 24:1547-1548. http://dx.doi.org/10.1093/bioinformatics/btn224.
19. Smyth GK. 2004. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat Appl. Genet. Mol. Biol. 3:Article3. http://dx.doi.org/10.2202/1544-6115.1027.
20. Eisen MB, Spellman PT, Brown PO, Botstein D. 1998. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:14863-14868. http://dx.doi.org/10.1073/pnas.95.25.14863.
21. Everitt B, Landau S, Leese M. 2001. Cluster analysis, 4th ed. Oxford University Press, London, United Kingdom.
22. Ihaka R, Gentleman R. 1996. R: a language for data analysis and graphics. J. Comput. Graph. Stat. 5:299-314.
23. Dennis G, Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol. 4:P3. http://dx.doi.org/10.1186/gb-2003-4-5-p3.
24. Sinclair J. 2008. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J. Clin. Virol. 41:180-185. http://dx.doi.org/10.1016/j.jcv.2007.11.014.
25. Keyes LR, Hargett D, Soland M, Bego MG, Rossetto CC, Almeida-Porada G, St Jeor S. 2012. HCMV protein LUNA is required for viral reactivation from latently infected primary CD14(+) cells. PLoS One 7:e52827. http://dx.doi.org/10.1371/journal.pone.0052827.
26. Smith MS, Bentz GL, Smith PM, Bivins ER, Yurochko AD. 2004. HCMV activates PI(3)K in monocytes and promotes monocyte motility and transendothelial migration in a PI(3)K-dependent manner. J. Leukoc. Biol. 76:65-76. http://dx.doi.org/10.1189/jlb.1203621.
27. Smith MS, Bivins-Smith ER, Tilley AM, Bentz GL, Chan G, Minard J, Yurochko AD. 2007. Roles of phosphatidylinositol 3-kinase and NFkappaB in human cytomegalovirus-mediated monocyte diapedesis and adhesion: strategy for viral persistence. J. Virol. 81:7683-7694. http://dx.doi.org/10.1128/JVI.02839-06.
28. Bego M, Maciejewski J, Khaiboullina S, Pari G, St Jeor S. 2005. Characterization of an antisense transcript spanning the UL81-82 locus of human cytomegalovirus. J. Virol. 79:11022-11034. http://dx.doi.org/10.1128/JVI.79.17.11022-11034.2005.
29. Jenkins C, Abendroth A, Slobedman B. 2004. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. J. Virol. 78:1440-1447. http://dx.doi.org/10.1128/JVI.78.3.1440-1447.2004.
30. Goodrum F, Reeves M, Sinclair J, High K, Shenk T. 2007. Human cytomegalovirus sequences expressed in latently infected individuals promote a latent infection in vitro. Blood 110:937-945. http://dx.doi.org/10.1182/blood-2007-01-070078.
31. Beisser PS, Laurent L, Virelizier JL, Michelson S. 2001. Human cytomegalovirus chemokine receptor gene US28 is transcribed in latently infected THP-1 monocytes. J. Virol. 75:5949-5957. http://dx.doi.org/10.1128/JVI.75.13.5949-5957.2001.
32. Rossetto CC, Tarrant-Elorza M, Pari GS. 2013. Cis and trans acting factors involved in human cytomegalovirus experimental and natural latent infection of CD14(+) monocytes and CD34(+) cells. PLoS Pathog. 9:e1003366. http://dx.doi.org/10.1371/journal.ppat.1003366.
33. Huang MM, Kew VG, Jestice K, Wills MR, Reeves MB. 2012. Efficient human cytomegalovirus reactivation is maturation dependent in the Langerhans dendritic cell lineage and can be studied using a CD14+ experimental latency model. J. Virol. 86:8507-8515. http://dx.doi.org/10.1128/JVI.00598-12.
34. Reeves MB, Compton T. 2011. Inhibition of inflammatory interleukin-6 activity via extracellular signal-regulated kinase-mitogen-activated protein kinase signaling antagonizes human cytomegalovirus reactivation from dendritic cells. J. Virol. 85:12750-12758. http://dx.doi.org/10.1128/JVI.05878-11.
35. Cheung AK, Abendroth A, Cunningham AL, Slobedman B. 2006. Viral gene expression during the establishment of human cytomegalovirus latent infection in myeloid progenitor cells. Blood 108:3691-3699. http://dx.doi.org/10.1182/blood-2005-12-026682.
36. Chambers J, Angulo A, Amaratunga D, Guo H, Jiang Y, Wan JS, Bittner A, Frueh K, Jackson MR, Peterson PA, Erlander MG, Ghazal P. 1999. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73:5757-5766.
37. Montag C, Wagner JA, Gruska I, Vetter B, Wiebusch L, Hagemeier C. 2011. The latency-associated UL138 gene product of human cytomegalovirus sensitizes cells to tumor necrosis factor alpha (TNF-alpha) signaling by upregulating TNF-alpha receptor 1 cell surface expression. J. Virol. 85:11409-11421. http://dx.doi.org/10.1128/JVI.05028-11.
38. Kondo K, Kaneshima H, Mocarski ES. 1994. Human cytomegalovirus latent infection of granulocyte-macrophage progenitors. Proc. Natl. Acad. Sci. U. S. A. 91:11879-11883. http://dx.doi.org/10.1073/pnas.91.25.11879.
39. Morrison SJ, Uchida N, Weissman IL. 1995. The biology of hematopoietic stem cells. Annu. Rev. Cell Dev. Biol. 11:35-71. http://dx.doi.org/10.1146/annurev.cb.11.110195.000343.
40. Simmons D, Seed B. 1988. Isolation of a cDNA encoding CD33, a differentiation antigen of myeloid progenitor cells. J. Immunol. 141:2797-2800.
41. Tieu BC, Lee C, Sun H, Lejeune W, Recinos A 3rd, Ju X, Spratt H, Guo DC, Milewicz D, Tilton RG, Brasier AR. 2009. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J. Clin. Invest. 119:3637-3651. http://dx.doi.org/10.1172/JCI38308.
42. Chan G, Bivins-Smith ER, Smith MS, Smith PM, Yurochko AD. 2008. Transcriptome analysis reveals human cytomegalovirus reprograms monocyte differentiation toward an M1 macrophage. J. Immunol. 181: 698-711. http://dx.doi.org/10.4049/jimmunol.181.1.698.
43. Chan G, Nogalski MT, Yurochko AD. 2012. Human cytomegalovirus stimulates monocyte-to-macrophage differentiation via the temporal regulation of caspase 3. J. Virol. 86:10714-10723. http://dx.doi.org/10.1128/JVI.07129-11.
44. Van den Heuvel MM, Tensen CP, van As JH, Van den Berg TK, Fluitsma DM, Dijkstra CD, Dopp EA, Droste A, Van Gaalen FA, Sorg C, Hogger P, Beelen RH. 1999. Regulation of CD 163 on human macrophages: cross-linking of CD163 induces signaling and activation. J. Leukoc. Biol. 66:858-866.
45. Chesnut RW, Grey HM. 1985. Antigen presenting cells and mechanisms of antigen presentation. Crit. Rev. Immunol. 5:263-316.
46. Hartnell A, Steel J, Turley H, Jones M, Jackson DG, Crocker PR. 2001. Characterization of human sialoadhesin, a sialic acid binding receptor expressed by resident and inflammatory macrophage populations. Blood 97:288-296. http://dx.doi.org/10.1182/blood.V97.1.288.
47. Slobedman B, Stern JL, Cunningham AL, Abendroth A, Abate DA, Mocarski ES. 2004. Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. J. Virol. 78:4054-4062. http://dx.doi.org/10.1128/JVI.78.8.4054-4062.2004.
48. Smith MS, Bentz GL, Alexander JS, Yurochko AD. 2004. Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence. J. Virol. 78:4444-4453. http://dx.doi.org/10.1128/JVI.78.9.4444-4453.2004.
49. Tacke F, Randolph GJ. 2006. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 211:609-618. http://dx.doi.org/10.1016/j.imbio.2006.05.025.
50. Gredmark S, Soderberg-Naucler C. 2003. Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J. Virol. 77:10943-10956. http://dx.doi.org/10.1128/JVI.77.20.10943-10956.2003.
51. Zhu H, Cong JP, Shenk T. 1997. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. U. S. A. 94:13985-13990. http://dx.doi.org/10.1073/pnas.94.25.13985.
52. DeFilippis VR, Sali T, Alvarado D, White L, Bresnahan W, Fruh KJ. 2010. Activation of the interferon response by human cytomegalovirus occurs via cytoplasmic double-stranded DNA but not glycoprotein B. J. Virol. 84:8913-8925. http://dx.doi.org/10.1128/JVI.00169-10.
53. Simmen KA, Singh J, Luukkonen BG, Lopper M, Bittner A, Miller NE, Jackson MR, Compton T, Fruh K. 2001. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. U. S. A. 98:7140-7145. http://dx.doi.org/10.1073/pnas.121177598.
54. Compton T, Kurt-Jones EA, Boehme KW, Belko J, Latz E, Golenbock DT, Finberg RW. 2003. Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:4588-4596. http://dx.doi.org/10.1128/JVI.77.8.4588-4596.2003.
55. Soderberg-Naucler C. 2006. Does cytomegalovirus play a causative role in the development of various inflammatory diseases and cancer? J. Intern. Med. 259:219-246. http://dx.doi.org/10.1111/j.1365-2796.2006.01618.x.
56. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K. 2010. Development of monocytes, macrophages, and dendritic cells. Science 327:656-661. http://dx.doi.org/10.1126/science.1178331.
57. Yurochko AD, Huang ES. 1999. Human cytomegalovirus binding to human monocytes induces immunoregulatory gene expression. J. Immunol. 162:4806-4816.
58. Qiu H, Straat K, Rahbar A, Wan M, Soderberg-Naucler C, Haeggstrom JZ. 2008. Human CMV infection induces 5-lipoxygenase expression and leukotriene B4 production in vascular smooth muscle cells. J. Exp. Med. 205:19-24. http://dx.doi.org/10.1084/jem.20070201.
59. Maussang D, Verzijl D, van Walsum M, Leurs R, Holl J, Pleskoff O, Michel D, van Dongen GA, Smit MJ. 2006. Human cytomegalovirusencoded chemokine receptor US28 promotes tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 103:13068-13073. http://dx.doi.org/10.1073/pnas.0604433103.
60. Uguccioni M, Loetscher P, Forssmann U, Dewald B, Li H, Lima SH, Li Y, Kreider B, Garotta G, Thelen M, Baggiolini M. 1996. Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin. J. Exp. Med. 183:2379-2384. http://dx.doi.org/10.1084/jem.183.5.2379.
61. Patel VP, Kreider BL, Li Y, Li H, Leung K, Salcedo T, Nardelli B, Pippalla V, Gentz S, Thotakura R, Parmelee D, Gentz R, Garotta G. 1997. Molecular and functional characterization of two novel human C-C chemokines as inhibitors of two distinct classes of myeloid progenitors. J. Exp. Med. 185:1163-1172. http://dx.doi.org/10.1084/jem.185.7.1163.
62. Mason GM, Poole E, Sissons JG, Wills MR, Sinclair JH. 2012. Human cytomegalovirus latency alters the cellular secretome, inducing cluster of differentiation (CD)4+T-cell migration and suppression of effector function. Proc. Natl. Acad. Sci. U. S. A. 109:14538-14543. http://dx.doi.org/10.1073/pnas.1204836109.
63. Barber GN. 2011. Innate immune DNA sensing pathways: STING, AIMII and the regulation of interferon production and inflammatory responses. Curr. Opin. Immunol. 23:10-20. http://dx.doi.org/10.1016/j.coi.2010.12.015.
64. Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD. 2008. Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy. Nat. Biotechnol. 26: 1179-1186. http://dx.doi.org/10.1038/nbt.1500.
65. Shi C, Pamer EG. 2011. Monocyte recruitment during infection and inflammation. Nat. Rev. Immunol. 11:762-774. http://dx.doi.org/10.1038/nri3070.
66. Marshall EE, Geballe AP. 2009. Multifaceted evasion of the interferon response by cytomegalovirus. J. Interferon Cytokine Res. 29:609-619. http://dx.doi.org/10.1089/jir.2009.0064.
67. Umashankar M, Petrucelli A, Cicchini L, Caposio P, Kreklywich CN, Rak M, Bughio F, Goldman DC, Hamlin KL, Nelson JA, Fleming WH, Streblow DN, Goodrum F. 2011. A novel human cytomegalovirus locus modulates cell type-specific outcomes of infection. PLoS Pathog. 7:e1002444. http://dx.doi.org/10.1371/journal.ppat.1002444.
68. Chan G, Nogalski MT, Bentz GL, Smith MS, Parmater A, Yurochko AD. 2010. PI3K-dependent upregulation of Mcl-1 by human cytomegalovirus is mediated by epidermal growth factor receptor and inhibits apoptosis in short-lived monocytes. J. Immunol. 184:3213-3222. http://dx.doi.org/10.4049/jimmunol.0903025.
69. Daley-Bauer LP, Roback LJ, Wynn GM, Mocarski ES. 2014. Cytomegalovirus hijacks CX3CR1(hi) patrolling monocytes as immune-privileged vehicles for dissemination in mice. Cell Host Microbe 15:351-362. http://dx.doi.org/10.1016/j.chom.2014.02.002.
70. Amsler L, Verweij MC, DeFilippis VR. 2013. The tiers and dimensions of evasion of the type I interferon response by human cytomegalovirus. J. Mol. Biol. 425:4857-4871. http://dx.doi.org/10.1016/j.jmb.2013.08.023.